Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)

SIMPLE SUMMARY: Myelodysplastic syndromes are a group of clonal disorders originating from hematopoietic stem and progenitor cells. Due to their heterogenous nature, prognostic stratification as well as therapeutic management remain a challenge. For the majority of MDS patients, treatment strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasprzak, Annika, Nachtkamp, Kathrin, Gattermann, Norbert, Germing, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032854/
https://www.ncbi.nlm.nih.gov/pubmed/35454847
http://dx.doi.org/10.3390/cancers14081941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032854/
https://www.ncbi.nlm.nih.gov/pubmed/35454847
http://dx.doi.org/10.3390/cancers14081941

Ejemplares similares